No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis

OBJECTIVE: Preexposure prophylaxis (PrEP) with emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) reduced HIV acquisition in the iPrEx trial among men who have sex with men and transgender women. Self-reported sexual risk behavior decreased overall, but may be affected by reporting bias. We evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcus, Julia L., Glidden, David V., Mayer, Kenneth H., Liu, Albert Y., Buchbinder, Susan P., Amico, K. Rivet, McMahan, Vanessa, Kallas, Esper Georges, Montoya-Herrera, Orlando, Pilotto, Jose, Grant, Robert M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867330/
https://www.ncbi.nlm.nih.gov/pubmed/24367497
http://dx.doi.org/10.1371/journal.pone.0081997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867330/
https://www.ncbi.nlm.nih.gov/pubmed/24367497
http://dx.doi.org/10.1371/journal.pone.0081997

Ejemplares similares